|Ms. Michelle Gallaher||Chief Exec. Officer||278.48k||N/A||N/A|
|Mr. Damon Rasheed||Exec. Director||55.24k||N/A||N/A|
|Mr. Shane Lewis||VP of Sales & Partnerships||N/A||N/A||N/A|
|Mr. Scott Sorochak||Chief Revenue Officer||N/A||N/A||N/A|
|Mr. Jason Weaver||Chief Product Officer & Advisor||N/A||N/A||N/A|
|Mr. David Iilja M.B.A.||Company Sec.||N/A||N/A||N/A|
Opyl Limited develops digital tools that improves healthcare experience for patients in Australia. It also offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials; and social media marketing agency services, such as client and account management services for pharmaceutical, medtech, and biotech industries. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.
Opyl Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.